Avenir Wellness Solutions, Inc.
AVRW · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.01 | 0.03 | -0.05 |
| FCF Yield | -73.65% | -91.40% | -19.75% | -16.93% |
| EV / EBITDA | -4.23 | -1.10 | -6.57 | -2.80 |
| Quality | ||||
| ROIC | 343.48% | -618.06% | -34.63% | -46.36% |
| Gross Margin | 71.52% | 68.20% | 71.22% | 47.54% |
| Cash Conversion Ratio | 1.12 | 0.39 | 0.33 | 0.32 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.57% | 33.65% | 113.68% | 1,270,440.62% |
| Free Cash Flow Growth | 61.32% | -127.25% | 57.42% | -22.33% |
| Safety | ||||
| Net Debt / EBITDA | -2.57 | -0.43 | -2.51 | -0.54 |
| Interest Coverage | -96.60 | -39.29 | -16.24 | -7.67 |
| Efficiency | ||||
| Inventory Turnover | 6.22 | 10.74 | 2.46 | 2.40 |
| Cash Conversion Cycle | -544.85 | -36.82 | -784.11 | -532.06 |